Stomach Surgery Slows Alzheimer’s Disease in Mice, Study Finds

A single operation on the stomach may do more than shrink the waistline. In a study published in Aging Cell, researchers at the University of Wisconsin–Madison report that sleeve gastrectomy, the most commonly performed bariatric procedure worldwide, slowed the progression of Alzheimer’s disease in a transgenic mouse model, reducing amyloid plaque burden, damping neuroinflammation, and, under conditions of sustained dietary stress, rescuing spatial memory deficits. The findings offer the first preclinical evidence that metabolic surgery can act as a disease-modifying intervention for Alzheimer’s disease, and they arrive at a moment when the search for accessible, durable therapies has become increasingly urgent.

The rationale for the work rests on a well-documented but incompletely understood connection between metabolism and neurodegeneration. Obesity and type 2 diabetes are established risk factors for Alzheimer’s disease, and midlife obesity is associated with roughly a doubling of dementia risk. Insulin resistance, systemic inflammation, and impaired cerebral glucose uptake all appear to feed the pathological cascade that produces amyloid-beta plaques and neurofibrillary tangles. Dietary interventions such as caloric restriction, protein restriction, and intermittent fasting have each shown benefits in mouse models, but their translation to humans has been hampered by poor long-term adherence. Incretin-based drugs targeting the GLP-1 and GIP receptors, meanwhile, have produced mixed results in preclinical studies and, in recent phase 3 trials of semaglutide in early-stage Alzheimer’s disease, failed to demonstrate cognitive benefit.

Bariatric surgery occupies a different position in this landscape. Unlike diets that demand daily willpower or drugs that require indefinite adherence, sleeve gastrectomy is a one-time intervention with lifelong effects, achieving rapid and durable weight loss along with resolution of obesity-related metabolic disease. Human studies have hinted at neurological dividends: neuroimaging reveals structural and functional brain changes after surgery, cognitive improvements have been documented as early as twelve weeks postoperatively, and a recent retrospective cohort study linked bariatric surgery to reduced incidence of mild cognitive impairment and Alzheimer’s-related dementias. What remained unknown was whether the surgery directly alters Alzheimer’s-specific pathology, and through what mechanisms.

To answer that question, the team turned to the 3xTg-AD mouse, an animal that carries familial human variants of three Alzheimer’s-related genes—APP, tau, and presenilin—and develops the cardinal features of the human disease, including amyloid plaques, tangles, and progressive cognitive decline. Female mice were fed a Western diet for two months to induce obesity and glucose intolerance, mimicking the metabolic profile of patients seeking bariatric surgery, and were then randomized to receive either sleeve gastrectomy or a sham operation. After surgery, one cohort was maintained on a standard control diet while a second remained on the obesogenic Western diet for life, allowing the researchers to test the surgery’s effects both under baseline conditions and under sustained metabolic stress.

The metabolic results were striking for what they did not involve. Across twelve months of follow-up, operated mice gained less weight than sham controls in both dietary contexts, an effect driven almost entirely by reduced fat mass, with lean mass actually preserved or increased. Yet cumulative food intake was identical between groups, and measurements in metabolic chambers showed no differences in energy expenditure or substrate utilization. The body-composition shift, in other words, was not the product of eating less or burning more. In the control-fed cohort, the surgery also significantly improved insulin sensitivity on a tolerance test—an effect seen in the transgenic mice but not in wild-type littermates—even though glucose tolerance itself was unchanged, suggesting compensatory adaptations specific to the Alzheimer’s-prone background.

When the researchers examined the brains of fifteen-month-old animals, the neuropathological signature was unmistakable. Sleeve gastrectomy significantly reduced the percentage of cortical area occupied by amyloid plaques, with a parallel trend toward fewer plaques, and the effect was accompanied by reduced immunoreactivity for GFAP, a marker of reactive astrocytes, and IBA1, a marker of activated microglia—the two cellular faces of Alzheimer’s neuroinflammation. Notably, these changes were confined to the cortex; the hippocampus showed no significant differences. The regional pattern is consistent with the well-described spatiotemporal progression of Alzheimer’s disease, in which pathology first emerges in neocortical regions before spreading to medial temporal structures, raising the possibility that the surgery intervenes at an early stage of pathological propagation.

Tau phosphorylation told a more nuanced story. The surgery produced epitope-specific effects: a strong trend toward reduced phosphorylation at threonine 231, an early and clinically relevant event mediated by the kinase GSK-3β, alongside a significant increase in the AT8 epitope, which is associated with more established tangle pathology. The authors interpret this divergence as evidence that the surgery is most effective at modulating early-stage tau phosphorylation, before mature paired helical filaments form, though they acknowledge that fully powered comparisons across genotypes will be needed to resolve the pattern.

Perhaps the most mechanistically revealing findings came from the autophagy analysis. Autophagy, the cellular machinery that clears misfolded proteins and damaged organelles, is known to fail in Alzheimer’s disease, contributing to the accumulation of plaques and tangles. In the cortex of operated mice, where plaque burden had already fallen, the initiation proteins ATG5, ATG7, and ATG16L1 were downregulated and the cargo receptor p62 was reduced—consistent with a homeostatic dialing-back of autophagic demand once pathological load had been cleared. In the hippocampus, where plaque burden remained elevated, the opposite occurred: ATG7 and ATG16L1 were upregulated, LC3A/B increased, and p62 dropped sharply, indicating enhanced autophagic flux and active cargo clearance. The opposing patterns tracked inversely with phosphorylated AKT, an upstream inhibitor of autophagy initiation through the mTORC1 pathway, suggesting that restored insulin signaling after surgery may extend to the brain and drive region-specific modulation of the insulin–autophagy axis.

Cognition added a final layer of complexity. In the control-fed cohort, behavioral testing at five and eight months after surgery revealed no differences between operated and sham mice on the Barnes maze, fear conditioning, or novel object recognition—but neither did sham mice differ from wild-type animals, indicating that the standard diet had failed to produce a measurable cognitive deficit for the surgery to rescue. Under lifelong Western diet exposure, however, the picture changed dramatically. Sham-fed transgenic mice showed clear spatial memory impairment, and sleeve gastrectomy substantially rescued it: operated mice found the escape box faster, with higher success rates and shorter search paths, in both short- and long-term memory probes. The same animals also showed significantly reduced plaque numbers, reduced phosphorylated tau, visually attenuated glial activation, and—extending the benefits beyond the brain—significantly lower frailty scores across the study period, a measure of accumulated age-associated deficits that was also reduced in wild-type operated mice.

The authors are careful about limitations. The study used only female mice, because males in the available colony do not reliably develop the disease phenotype; the Western diet cohort suffered substantial age-associated mortality that reduced group sizes; autophagic flux was inferred from protein markers rather than measured directly; and survival analysis was underpowered, with no difference detected between surgical groups in either diet. Even so, the convergence of evidence—reduced adiposity, improved insulin sensitivity, attenuated cortical amyloid and glial activation, region-specific autophagy remodeling, rescued spatial memory, and reduced frailty—constitutes a compelling proof of concept. Critically, the neuroprotective effects are unlikely to be mediated solely through the GLP-1 axis: fasting GLP-1 rose in wild-type but not transgenic operated mice, and prior work has shown that sleeve gastrectomy’s metabolic benefits persist in GLP-1 receptor knockout animals. That mechanistic breadth may explain why a single surgical intervention succeeded where incretin pharmacotherapy has so far fallen short in Alzheimer’s trials. Whether the benefits translate to humans remains an open question, but the study establishes metabolic surgery as a serious candidate for disease modification in obesity-associated Alzheimer’s disease—and points the field toward the gut–brain pathways that make the stomach, unexpectedly, a target organ for the brain.

Subject of Research: Effects of sleeve gastrectomy on metabolic health, cognition, and Alzheimer's disease pathology in a transgenic mouse model

Article Title: Sleeve Gastrectomy Improves Metabolic Health, Cognition, and Alzheimer's Disease Pathology in 3xTG Mice

Article References: Babygirija, R., Illiano, J. A., Sonsalla, M. M., Zhu, G., Jabbarpour, C. R., Mathew, T., Molkentin, T., Peterson, M., Winder, C., Nair, A. R. K., Xiao, F., Wolter, J. M., Lamming, D. W., & Harris, D. A. (2026). Sleeve Gastrectomy Improves Metabolic Health, Cognition, and Alzheimer's Disease Pathology in 3xTG Mice. Aging Cell, 25(10), Article e70767. https://doi.org/10.1111/acel.70767

Image Credits: AI Generated

DOI: 10.1111/acel.70767

Keywords: sleeve gastrectomy, Alzheimer's disease, bariatric surgery, 3xTg-AD mice, amyloid plaques, tau phosphorylation, autophagy, insulin sensitivity, neuroinflammation, Western diet, GLP-1, spatial memory